These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34764340)

  • 1. The effect of spacers in dual drug-polymer conjugates toward combination therapeutic efficacy.
    Xu J; Ma M; Mukerabigwi JF; Luo S; Zhang Y; Cao Y; Ning L
    Sci Rep; 2021 Nov; 11(1):22116. PubMed ID: 34764340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy.
    Luo S; Gu Y; Zhang Y; Guo P; Mukerabigwi JF; Liu M; Lei S; Cao Y; He H; Huang X
    Mol Pharm; 2015 Jul; 12(7):2318-27. PubMed ID: 26035636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L; Zhou M; Huang Y
    Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
    Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
    Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
    Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
    Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance.
    Cao Y; Chen D; Zhao P; Liu L; Huang X; Qi C; Liu Y; He H; Wang Q; Liu Y; Chen S
    Ann Biomed Eng; 2011 Sep; 39(9):2456-65. PubMed ID: 21701935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
    Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
    J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer.
    Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA
    Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.
    Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
    J Drug Target; 2004; 12(8):477-89. PubMed ID: 15621674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.
    Zhang RX; Zhang T; Chen K; Cheng J; Lai P; Rauth AM; Pang KS; Wu XY
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29053672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.
    Pawar S; Mahajan K; Vavia P
    AAPS PharmSciTech; 2017 Nov; 18(8):3021-3033. PubMed ID: 28497240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer nanomedicines with enzymatically triggered activation: A comparative study of in vitro and in vivo anti-cancer efficacy related to the spacer structure.
    Pechar M; Pola R; Studenovský M; Bláhová M; Grosmanová E; Dydowiczová A; Filipová M; Islam R; Gao S; Fang J; Etrych T
    Nanomedicine; 2022 Nov; 46():102597. PubMed ID: 36064033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H; Etrych T; Ríhová B; Kostka L; Starovoytová L; Kovář M; Ulbrich K
    Macromol Biosci; 2013 Dec; 13(12):1648-60. PubMed ID: 24031022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
    Xiang Y; Chen L; Zhou R; Huang Y
    Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.